The Program for Advanced Cellular Therapy is excited to announce the promotion of Andrea Pennati, Ph.D., to Director of Research and Development. In this role, Dr. Pennati is responsible for the transition of UW’s pre-clinical …
Uncategorized
Galipeau speaks at Neurosurgery Grand Rounds
Jacques Galipeau, MD, FRCP, PACT Director, recently presented at the Department of Neurosurgery Grand Rounds. The full presentation, “Mesenchymal Stromal Cells for TBI – A first-in-human clinical trial proposal,” can be viewed below:
KIM MCDOWELL PROMOTED TO DIRECTOR OF REGULATORY AFFAIRS FOR PROGRAM FOR ADVANCED CELL THERAPY
Kimberly McDowell, MD, PhD, has been named Director of Regulatory Affairs for the UW Program for Advanced Cell Therapy (PACT). McDowell has served as the program’s associate director of regulatory affairs since 2019, and has …
Galipeau Chats with UWCCC Emerging Leadership Board
In December 2020, PACT Director Jacques Galipeau took part in Emerging Leadership Board at UW Carbone Cancer Center’s Five Minutes at Five Q&A session about his work in the PACT Program. To view the interview, …
UW Carbone Cancer Center Receives FDA Clearance to Test New Regenerative Medicine Therapy for Radiotherapy-Induced Dry Mouth
The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy. This investigational new drug license, or IND, recently …
UW Program launches first-in-US cell-therapy trial for kidney transplant patients
MADISON, Wis. – For the first time in the United States, a research team will test a personalized cell therapy to treat a common and serious complication facing kidney transplant patients. The UW Program for …
Kim McDowell Hired as Associate Director of Regulatory Affairs
Dr. Kim McDowell has been appointed to oversee the regulatory affairs of the Program for Advanced Cell Therapy (PACT). Her main duties will include crafting and managing investigational new drug (IND) and investigational device exemption …
PACT Names Ross O. Meyers New Director of Cell Manufacturing
The Program for Advanced Cell Therapy (PACT) has selected a new director of cell manufacturing. Ross Meyers will oversee the program’s Good Manufacturing Practice (GMP) lab operations and advanced cell manufacturing as the program works …
Cellular Pharmaceuticals Meet The Wisconsin Idea
Traditionally, drug development arises from a university discovery for which a pharmaceutical company acquires the rights and thereafter navigates the path to market approval. This process of shepherding a therapeutic discovery to become a U.S. …
PACT Featured as Isthmus Project Startup
The Isthmus Project, a new business accelerator program at UW Health, has already accepted two startups and is considering several more. Of the two approved startups, Mackie says one would make a good not-for-profit or …